Gregory Carr, Ph.D.

Investigator

About

Research

Selected Publications

Team Members

Curriculum Vitae

About

About

Gregory Carr, Ph.D. is an Investigator in the Drug Discovery Division of the Lieber Institute and an Assistant Professor in the Johns Hopkins University School of Medicine Department of Pharmacology and Molecular Sciences. Dr. Carr leads the in vivo pharmacology research group with the goal of identifying novel therapeutics for the treatment of neurological and psychiatric disorders. Dr. Carr received a BA in Neuroscience from Kenyon College and his PhD in Neuroscience from the University of Pennsylvania. Prior to joining the Lieber Institute, Dr. Carr was a postdoctoral fellow in the Clinical Brain Disorders Branch of the National Institute of Mental Health and an adjunct instructor in the Department of Biology at Howard University.

Research

Research

Psychiatric disorders and related neurodevelopmental disorders result from the complex interaction of multiple genetic and environmental risk factors. Our laboratory uses rodent models to determine how these risk factors modulate neurobiology and behavior. We utilize neurochemical, electrophysiological, and behavioral assays to interrogate the neural systems thought to be abnormal in neurodevelopmental disorders. Our ultimate goal is to use this knowledge to inform drug discovery efforts designed to increase and improve the treatment options available for central nervous system disorders. We also conduct research focused on developing novel behavioral assays with increased translational value for screening novel therapeutics.